Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Thruvision Group PLC Director's Dealing 2023

Feb 3, 2023

7968_dirs_2023-02-03_a51e4e1e-7df5-4b0a-84a0-a610390abd48.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 8035O

Thruvision Group PLC

03 February 2023

hruvision_logo_sm

3 February 2023

Thruvision Group plc

("Thruvision" or the "Group")

Sharesave option grant to Executive Director

Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market announces a grant of share options under the Thruvision Sharesave Scheme (the "Scheme").

The Remuneration Committee of the Group have granted, under the rules of the Scheme, an option over 81,447 Ordinary 1p shares with an exercise price of 17.68 pence per share to Victoria Balchin.

The exercise price, set on 11 January 2023, is calculated on the basis of 80% of the closing middle market price of Thruvision shares on 11 January 2023. The option may be exercised between 1 March 2026 and 31 August 2026, assuming the conditions of the Scheme are met.

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:

1. Details of the person discharging managerial responsibilities/person closely associated
(a) Name Victoria Balchin
2. Reason for the notification
(a) Position/status Chief Financial Officer
(b) Initial notification/ Amendment Initial notification
3. Details of the issuer
(a) Name Thruvision Group plc
(b) LEI 213800IZG9GM6G2TZE04
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a) Description of the Financial Instrument Ordinary shares of £0.01 each
(b) Identification code of the Financial Instrument GB00B627R876
(c) Nature of the transaction Grant of Options under the Sharesave Scheme.
(d) Price(s) and volume(s) Price(s) Volume(s)
17.68p 81,447
(e) Aggregated information

-           Aggregated volume

-           Price
N/A
(f) Date of the transaction 3 February 2023
(g) Place of the transaction Not a trading venue

For further information please contact:

Thruvision Group plc                                                                     +44 (0)1235 425400

Tom Black, Executive Chairman

Colin Evans, Chief Executive

Investec Investment Banking (NOMAD & Broker)                  +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

FTI Consulting LLP                                                                           +44 (0)20 3727 1000

Matt Dixon

About Thruvision

Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford, and Washington DC.

www.thruvision.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFFTFTIFIIV